Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian Cancer

Antonia Digklia1,2, George Coukos2,3,4, Krisztian Homicsko2,3,4,5

  • 1Department of Oncology, Medical Oncology Service, Lausanne University Hospital, Lausanne, Switzerland.